© Foto: picture alliance / Laci Perenyi | Laci Perenyi
© 2024 wallstreetONLINE
Realtime | Geld | Brief | Zeit |
---|---|---|---|
100,20 | 100,60 | 15:35 | |
100,10 | 100,50 | 15:35 |
© Foto: picture alliance / Laci Perenyi | Laci Perenyi
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
15:18 | BioNTech SE - 6-K, Report of foreign issuer | ||
15:00 | CHMP Recommends Marketing Authorization For Pfizer, BioNTech's Omicron KP.2-adapted COVID-19 Vaccine | NEW YORK CITY (dpa-AFX) - Pfizer (PFE) and BioNTech SE (BNTX) announced that the CHMP of the European Medicines Agency has recommended marketing authorization for the companies' Omicron KP.2-adapted... ► Artikel lesen | |
14:59 | CHMP Recommends Marketing Authorization For Pfizer, BioNTech's Omicron KP.2-adapted COVID-19 Vaccine | ||
14:22 | BioNTech SE: Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an Omikron KP.2 angepassten COVID-19-Impfstoff in der Europäischen Union | Der an Omikron KP.2 angepasste COVID-19-Impfstoff wird nach Zulassung durch die Europäische Kommission für Personen ab 6 Monaten verfügbar seinDaten zeigten, dass der an Omikron KP.2 angepasste COVID-19-Impfstoff... ► Artikel lesen | |
14:12 | Pfizer Inc.: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union | Upon authorization by the European Commission (EC), the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron... ► Artikel lesen |